Scholars Central

Case reportPublished 16 May 2022

Therapeutic management of VA-ECMO support for cardiogenic shock: Two case reports

Authors: Hongfeng Yang, Jun Yan, Zhixin Yu, Yan Cai, Zhaochen Jin

Interventional Cardiology

Volume 14 · Issue 3 · Pages 501–504

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Cardiogenic shock is considered a serious stage of heart disease, and there is no better way to treat this. Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) is a well-established technology that can be used as potential life-saving measures in patients who present with cardiac arrest or severe hemodynamic instability by improving organ perfusion and oxygenation. However, it is usually complex and needs individualized decisions in a multidisciplinary approach to manage patients receiving extracorporeal membrane oxygenation, as defined clinical condition’s protocols are still lacking. Case presentation: One patient was a 44-year-old man with out-of-hospital ventricular fibrillation was transferred to our hospital after initial cardiopulmonary resuscitation. In the emergency department, he presented with ST-segment elevation extensive anterior wall myocardial infarction and cardiogenic shock with paroxysmal ventricular tachycardia. After transfer to intensive care unit, VA-ECMO was implanted due to worsening cardiogenic shock and recovered slowly thereafter. Another patient was a 58-year-old woman presented refractory hypotension. As a bridge-therapy, VA-ECMO support was implanted and then the patient was taken to the cardiac catheterization laboratory where she experienced Percutaneous Coronary Intervention (PCI) and implanted a drug-eluting stent in the right coronary artery. Due to acute kidney injury, continuous renal replacement therapy was given to facilitate the control of fluid access balance, the removal of inflammatory media. Conclusion: VA-ECMO is not only used as a temporary treatment strategy for cardiogenic shock, but also as a bridge-therapy. It is important to focus on improve the success rate of VA-ECMO treatment and avoid complications.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Interventional Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Hongfeng Yang”
  • BylineArticles whose byline prints “Jun Yan”
  • BylineArticles whose byline prints “Zhixin Yu”
  • BylineArticles whose byline prints “Yan Cai”
  • BylineArticles whose byline prints “Zhaochen Jin”